// App-Quantinova.ai

S226 : LOSS OF NR4A1 IS ASSOCIATED WITH HIGHER EXPRESSION OF IMMUNE CHECKPOINT COMPONENTS AND REDUCED T CELL-MEDIATED LYMPHOMA CELL KILLING IN AGGRESSIVE LYMPHOMA

Researchers

Presenter

  • Katrin Pansy

Principal Investigators

  • Karoline Fechter

  • Aditya Arra

  • Marta Szmyra

  • Sandra Haingartner

  • Alan Ramsay

  • Hildegard Greinix

  • Christine Beham-Schmid

  • Peter Neumeister

  • Alexander Deutsch

Medical Centers

  • Clinic for Experimental Pedriatics,Otto-von-Guericke-Universität ,Magdeburg,Germany

  • Institute of Pathology, Medical University of Graz, Graz, Austria

  • Institute of He

  • Division of Oncology, Medical University of Graz, Graz, Austria

  • Clinic for Experimental Pedriatics,Otto-von-Guericke-Universität ,Magdeburg,Germany

  • Lymphoma Immunology resear

  • Lymphoma Immunology research group,Kings 's College ,London,Vereinigtes Königreich

  • Lymphoma Immunology research group,Kings 's College ,London,Royaume-uni

  • Division of Hematology,Medical University of Graz,Graz,Oostenrijk

  • Lymphoma Immunology research group,Kings 's College ,London,Royaume-uni

  • Division of Oncology, Medical University of Graz, Graz, Austria

  • Institute of Pathology, Medical University of Graz, Graz, Austria

  • Clinic for Experimental Pedriatics,Otto-von-Guericke-Universität ,Magdeburg,Germany

  • Division of Pediatric Hemato-Oncology,Medical University Graz,Graz,Autriche

  • Clinic for Experimental Pedriatics,Otto-von-Guericke-Universität ,Magdeburg,Germany

  • Division of Hematol

  • Institute of Pathology, Medical University of Graz, Graz, Austria

  • Lymphoma Immunology research group,Kings 's College ,London,Royaume-uni

  • Clinic for Experimental Pedriatics,Otto-von-Guericke-Univ

  • Institute of Pathology, Medical University of Graz, Graz, Austria

  • Lymphoma Immunology research group,Kings 's College ,London,Vereinigtes Königreich

Locations

  • Austria

  • France

  • Germany

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Diffuse large B-cell lymphoma

Biomarkers

  • Nuclear receptor subfamily 4 group A member 1

  • Cluster of differentiation 8A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved